ACSL4 and metabolic dysfunction-associated steatohepatitis: In contrast, the metabolic NASH-HCC model does not exhibit any signs of liver fibrosis (see Supplementary Fig. 1L) and is hence largely unaffected by Acsl4 deficiency.